These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
834 related items for PubMed ID: 16958681
21. [Perisinusoidal stellate cells or Ito cells and their role in hepatic fibrosis]. Casu A, Canepa M, Nanni G. Pathologica; 1994 Oct; 86(5):467-99. PubMed ID: 7739873 [Abstract] [Full Text] [Related]
25. Ghrelin alleviates biliary obstruction-induced chronic hepatic injury in rats. Işeri SO, Sener G, Saglam B, Ercan F, Gedik N, Yeğen BC. Regul Pept; 2008 Feb 07; 146(1-3):73-9. PubMed ID: 17884193 [Abstract] [Full Text] [Related]
26. Cytokines and fibrogenesis. Friedman SL. Semin Liver Dis; 1999 Feb 07; 19(2):129-40. PubMed ID: 10422196 [Abstract] [Full Text] [Related]
27. Induction of cell death in activated hepatic stellate cells by targeted gene expression of the thymidine kinase/ganciclovir system. Janoschek N, van de Leur E, Gressner AM, Weiskirchen R. Biochem Biophys Res Commun; 2004 Apr 16; 316(4):1107-15. PubMed ID: 15044099 [Abstract] [Full Text] [Related]
30. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice. Giebeler A, Boekschoten MV, Klein C, Borowiak M, Birchmeier C, Gassler N, Wasmuth HE, Müller M, Trautwein C, Streetz KL. Gastroenterology; 2009 Jul 15; 137(1):297-308, 308.e1-4. PubMed ID: 19208365 [Abstract] [Full Text] [Related]
31. Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario. Parola M, Marra F, Pinzani M. Mol Aspects Med; 2008 Jul 15; 29(1-2):58-66. PubMed ID: 18022682 [Abstract] [Full Text] [Related]
33. Liver slices as a model to study fibrogenesis and test the effects of anti-fibrotic drugs on fibrogenic cells in human liver. van de Bovenkamp M, Groothuis GM, Meijer DK, Olinga P. Toxicol In Vitro; 2008 Apr 15; 22(3):771-8. PubMed ID: 18207697 [Abstract] [Full Text] [Related]
35. Antifibrotic properties of botanicals in chronic liver disease. Stickel F, Brinkhaus B, Krähmer N, Seitz HK, Hahn EG, Schuppan D. Hepatogastroenterology; 2002 Feb 15; 49(46):1102-8. PubMed ID: 12143213 [Abstract] [Full Text] [Related]
36. Liver extracellular matrix in health and disease. Bedossa P, Paradis V. J Pathol; 2003 Jul 15; 200(4):504-15. PubMed ID: 12845618 [Abstract] [Full Text] [Related]
37. Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo. De Minicis S, Candelaresi C, Marzioni M, Saccomano S, Roskams T, Casini A, Risaliti A, Salzano R, Cautero N, di Francesco F, Benedetti A, Svegliati-Baroni G. Gut; 2008 Mar 15; 57(3):352-64. PubMed ID: 17989109 [Abstract] [Full Text] [Related]
40. [Liver fibrosis: pathophysiology, diagnosis and treatment]. Pár A, Pár G. Orv Hetil; 2005 Jan 02; 146(1):3-13. PubMed ID: 15715367 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]